Our development and production network spans across the globe
Our services are available to partners worldwide. Our locations on three continents offer state-of-the-art manufacturing facilities, as well as the expert knowledge to help our partners make the most of them. We constantly invest in both capacity and capability.
Clinical and commercial supply
Development, manufacture, and launch of therapeutic proteins and antibodies
Single-use plant with bioreactors from 100 - 500 L
Aseptic Filling in vials for liquids and lyophilizates
Core technology: fed-batch large-scale manufacturing in 15,000 L bioreactors, N-1 perfusion processes in 2,000 L bioreactors
Clinical and commercial supply
Cell line and process development of proteins obtained from E. coli or yeast
Mammalian technology: 15,000 L capacity
Microbial technology: 30 – 6,000 L capacity
Specialists in microbial fermentation, manufacturing e.g., recombinant proteins, recombinant vaccines, antibody-mimetics and plasmid DNA
Clinical and commercial supply
Multiproduct manufacturing of proteins and antibodies in two separate trains
Stainless Steel and Single-Use bioreactors
2,000 L and 15,000 L capacity
